Century Therapeutics Files Definitive Proxy Statement
Ticker: IPSC · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1850119
| Field | Detail |
|---|---|
| Company | Century Therapeutics, INC. (IPSC) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, shareholder-voting
TL;DR
Century Therapeutics filed its proxy statement for the June 12, 2025 meeting. Shareholders vote on company matters.
AI Summary
Century Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 22, 2025, for its annual meeting on June 12, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company is based in Philadelphia, PA, and operates in the biological products sector.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting, including any proposals or director elections, and provides information for shareholders to make informed voting decisions.
Risk Assessment
Risk Level: low — A DEF 14A filing is a routine disclosure document for public companies and does not inherently represent a new risk to investors.
Key Numbers
- 20250422 — Filing Date (Date the DEF 14A was filed.)
- 20250612 — Meeting Date (Date of the shareholder meeting for which proxies are being solicited.)
Key Players & Entities
- Century Therapeutics, Inc. (company) — Registrant
- 0001104659-25-037419 (filing_id) — Accession Number
- 20250422 (date) — Filing Date
- 20250612 (date) — Meeting Date
- Philadelphia, PA (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by a company to solicit proxies from its shareholders for an upcoming shareholder meeting.
When was this DEF 14A filed by Century Therapeutics?
This DEF 14A filing was made on April 22, 2025.
What is the date of the shareholder meeting for which this proxy statement is filed?
The shareholder meeting for which this proxy statement is filed is scheduled for June 12, 2025.
Where is Century Therapeutics, Inc. headquartered?
Century Therapeutics, Inc. is headquartered in Philadelphia, PA.
What is the Standard Industrial Classification (SIC) code for Century Therapeutics?
The SIC code for Century Therapeutics is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding Century Therapeutics, Inc. (IPSC).